Human immunodeficiency virus testing among patients with tuberculosis at a University Hospital in Taiwan, 2000 to 2006

Journal of the Formosan Medical Association

Volumn 108, Issue 4, 2009, Pages 320-327

  Kung, Hsiang Chi ^a   Sun, Hsin Yun ^a   Chen, Mao Yuan ^a   Hsieh, Szu Min ^a   Sheng, Wang Huei ^a   Chen, Yee Chun ^a   Hung, Chien Ching ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

HIV antibodies; HIV testing; Human immunodeficiency virus; Taiwan; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; TAIWAN; TUBERCULOSIS; UNIVERSITY HOSPITAL;

EID: 65549146317     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60072-3     Document Type: Article

References (37)

1. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992;326:231-5.
2. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
3. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970;26:28-106.
4. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-8.
5. Reichman LB. The U-shaped curve of concern. Am Rev Respir Dis 1991;144:741-2.
6. Ahmed AB, Abubakar I, Delpech V, et al. The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999-2003. Thorax 2007;62:672-6.
7. Rose AM, Sinka K, Watson JM, et al. An estimate of the contribution of HIV infection to the recent rise in tuberculosis in England and Wales. Thorax 2002;57:442-5.
8. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO report WHO/HTM/TB/2006.362. Geneva: WHO, 2006.
9. Reid A, Scano F, Getahun H, et al. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis 2006;6: 483-95.
10. Pozniak AL, Miller RF, Lipman MC, et al. BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005. HIV Med 2005;6(Suppl 2):62-83.
11. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR Morb Mortal Wkly Rep 1989;38:236-8, 243-50.
12. International Standards for Tuberculosis Care, 2006. Available at: http://www.stoptb.org/resource_center/assets/documents/ istc_report.pdf [Date accessed: December 30, 2007]
13. Albalak R, O'Brien RJ, Kammerer JS, et al. Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004. Arch Intern Med 2007;167:2443-52.
14. Katz DJ, Hall WN, Keon NB, et al. HIV testing in patients with tuberculosis. Physician response to national recommendations. Am Rev Respir Dis 1993;147:1283-6.
15. Asch SM, London AS, Barnes PF, et al. Testing for human immunodeficiency virus infection among tuberculosis patients in Los Angeles. Am J Respir Crit Care Med 1997;155:378-81.
16. DeRiemer K, Soares EC, Dias SM, et al. HIV testing among tuberculosis patients in the era of antiretroviral therapy: a population-based study in Brazil. Int J Tuberc Lung Dis 2000;4:519-27.
17. Dart S, Alder D, Mamdani M, et al. HIV testing in TB clinics: a problem in practice? Thorax 2006;61:271-2.
18. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO report WHO/HTM/TB/2007.376. Geneva: WHO, 2007.
19. Center for Disease Control, Department of Health, Taiwan, R.O.C. Statistics of Communicable Diseases and Surveillance Report in Taiwan Area, 2004. Taipei: Center for Disease Control, Department of Health, Taiwan, R.O.C.
20. HIV/AIDS Reports 2007. Available at: http://www.cdc.gov.tw/ website_en/health%20topics/Communicable% 20Diseases%20&%20Prevention/ Issues%20of%20HIV-AIDS/Statistics%20of%20HIV-AIDS/Download%20HIV- AIDS%20Data.htm [Date accessed: December 31, 2007]
21. Wang JY, Lee LN, Chou CS, et al. Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol 2004;42: 4599-603.
22. Chiang CY, Wu IH, Yu MC, et al. Screening of human immunodeficiency virus infection in pulmonary tuberculosis patients in Taiwan. J Formos Med Assoc 1998;97:66-8.
23. Jones BE, Young SM, Antoniskis D, et al. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993;148:1292-7.
24. Yang Z, Kong Y, Wilson F, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 2004;38: 199-205.
25. Marshall BG, Mitchell DM, Shaw RJ, et al. HIV and tuberculosis co-infection in an inner London hospital - a prospective anonymized seroprevalence study. J Infect 1999;38:162-6.
26. Onorato IM, McCray E. Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis 1992;165:87-92.
27. Greenberg BL, Weisfuse IB, Makki H, et al. HIV-1 seroprevalence in chest clinic and hospital tuberculosis patients in New York City, 1989-1991. AIDS 1994;8:957-62.
28. Barnes PF, Silva C, Otaya M. Testing for human immunodeficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med 1996;153:1448-50.
29. Bowen EF, Rice PS, Cooke NT, et al. HIV seroprevalence by anonymous testing in patients with Mycobacterium tuberculosis and in tuberculosis contacts. Lancet 2000; 356:1488-9.
30. Mac-Arthur A, Gloyd S, Perdigao P, et al. Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int J Tuberc Lung Dis 2001;5:894-902.
31. Stout JE, Ratard R, Southwick KL, et al. Epidemiology of human immunodeficiency virus testing among patients with tuberculosis in North Carolina. South Med J 2002;95: 231-8.
32. Zachariah R, Spielmann MP, Chinji C, et al. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS 2003;17:1053-61.
33. Hussain T, Sinha S, Kulshreshtha KK, et al. Seroprevalence of HIV infection among tuberculosis patients in Agra, India - a hospital-based study. Tuberculosis (Edinb) 2006;86:54-9.
34. De Cock KM, Odhiambo J. HIV testing in patients with TB. Trop Doct 2006;36:71-3.
35. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21.
36. Lawn SD, Bekker LG, Middelkoop K, et al. Impact of HIV infection on the epidemiology of tuberculosis in a periurban community in South Africa: the need for age-specific interventions. Clin Infect Dis 2006;42:1040-7.
37. Chen YM, Kuo SH. HIV-1 in Taiwan. Lancet 2007;369:623-5.